Ig G4-related sclerosing cholangitis
GPTKB entity
Statements (50)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:disease
|
gptkbp:affects |
bile ducts
|
gptkbp:associated_with |
gptkb:Ig_G4-related_aortitis
gptkb:Ig_G4-related_kidney_disease gptkb:Ig_G4-related_lung_disease gptkb:Ig_G4-related_retroperitoneal_fibrosis gptkb:Ig_G4-related_skin_disease gptkb:Ig_G4-related_thyroiditis gptkb:Ig_G4-related_disease Ig G4-related orbital disease Ig G4-related hematological disorders Ig G4-related neurological disorders Ig G4-related salivary gland disease |
gptkbp:clinical_trial |
fatigue
weight loss lymphadenopathy sclerosing cholangitis |
gptkbp:complication |
gptkb:cholangiocarcinoma
|
gptkbp:condition |
autoimmune pancreatitis
|
gptkbp:demographics |
more common in men
|
gptkbp:diagnosis |
variable
imaging studies histological examination |
gptkbp:epidemiology |
global occurrence
|
gptkbp:events |
regular monitoring
|
https://www.w3.org/2000/01/rdf-schema#label |
Ig G4-related sclerosing cholangitis
|
gptkbp:is_tested_for |
elevated serum Ig G4 levels
|
gptkbp:pathway |
autoimmune process
|
gptkbp:photography |
gptkb:MRI
CT scan ultrasound |
gptkbp:prevalence |
rare
|
gptkbp:research_focus |
patient quality of life
improving diagnostic methods long-term outcomes developing new therapies understanding pathogenesis |
gptkbp:risk_factor |
other autoimmune diseases
chronic pancreatitis |
gptkbp:symptoms |
abdominal pain
jaundice |
gptkbp:treatment |
gptkb:surgery
antibiotics biologics pain management corticosteroids immunosuppressive therapy biliary drainage |
gptkbp:bfsParent |
gptkb:Ig_G4-related_disease
|
gptkbp:bfsLayer |
7
|